Aguilera, Oscar
Targeting KRAS Mutant CMS3 Subtype by Metabolic Inhibitors. [electronic resource]
- Advances in experimental medicine and biology
- 23-34 p. digital
Publication Type: Journal Article; Review
0065-2598
10.1007/978-3-030-02771-1_3 doi
Cell Line, Tumor
Colorectal Neoplasms--drug therapy
Drug Resistance, Neoplasm--genetics
Genes, ras
Humans
Molecular Targeted Therapy
Mutation
Proto-Oncogene Proteins p21(ras)--genetics